Works matching IS 09414355 AND DT 2016 AND VI 24 AND IP 7

Results: 49
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study.

    Published in:
    2016
    By:
    • Adra, Nabil;
    • Albany, Costantine;
    • Brames, Mary;
    • Case-Eads, Somer;
    • Johnson, Cynthia;
    • Liu, Ziyue;
    • Fausel, Christopher;
    • Breen, Timothy;
    • Hanna, Nasser;
    • Hauke, Ralph;
    • Picus, Joel;
    • Einhorn, Lawrence;
    • Brames, Mary J;
    • Johnson, Cynthia S;
    • Fausel, Christopher A;
    • Hanna, Nasser H;
    • Hauke, Ralph J;
    • Einhorn, Lawrence H
    Publication type:
    journal article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    Linguistic validation of the Spanish version of the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

    Published in:
    2016
    By:
    • Arnold, Benjamin;
    • Mitchell, Sandra;
    • Lent, Lauren;
    • Mendoza, Tito;
    • Rogak, Lauren;
    • Barragán, Natalie;
    • Willis, Gordon;
    • Medina, Mauricio;
    • Lechner, Suzanne;
    • Penedo, Frank;
    • Harness, Jay;
    • Basch, Ethan;
    • Mitchell, Sandra A;
    • Mendoza, Tito R;
    • Rogak, Lauren J;
    • Barragán, Natalie M;
    • Penedo, Frank J;
    • Harness, Jay K;
    • Basch, Ethan M;
    • PRO-CTCAE Spanish Translation and Linguistic Validation Study Group
    Publication type:
    journal article